Current issue

Issue image

Volume 53, Issue 4, 2025

Online ISSN: 2560-3310

ISSN: 0350-8773

Volume 53 , Issue 4, (2025)

Published: 30.06.2025.

Open Access

All issues

More Filters

Contents

01.01.2006.

Professional reviews

DIABETIC NEPHROP IABETIC NEPHROPATHIA AND ACE INHIBIT ACE INHIBITORS

Diabetes is the most common cause of end-stage renal disease .in United States , Europa and Japan. Approximately 40% of patients with type 1 diabetes and 5-15% of patients with type 2 diabetes eventually develop end-stage renal disease. Risk factors for development of diabetic nephropathy include hyperglycemia, hypertension, positive family history of nephropathy and hypertension, and smoking. Key elements in the primary care of diabetes include glycemic control, blood pressure control, and screening for microalbuminuria. In general, the goal for glycemic control is a blood glucose level as close to normal (HbA C <7%) . Blood pressure control is at least as important as glucose control, especially after the onset of 1 renal damage, and blood pressure should be consistently <130/85. Screening for diabetic nephropathy involves monitoring at least yearly for urinary albumin excretion >30 mg per day. Microalbuminuria is defined as the urinary excretion of 30300 mg of albumin per day. Both glycemic control and rigorous control of blood pressure have significant impact on prevention and progression of diabetic nephropathy. Identification of patients with microalbuminuria selects a population of patients with increased mortality. Microalbuminuria screening should begin at the time of diagnosis. ACE inhibitors should be used when microalbuminuria is present regardless of the presence or absence of hypertension in type 1 diabetes and are widely.
used in normotensive patients with type 2 diabetes, as well.The effect of ACE inhibitors is probably not only via lowered
systemic blood pressure but also via direct effects on intraglomerular hemodynamics. 

T. Novaković, S. Jovanović, S. Sovtić, S. Pajović, R. Stolić

01.12.2004.

Original scientific paper

ESSENTIAL CHARACTERISTICS OF REPEATED MYOCARDIAL INFARCTION

Bacterial meningitis is an important medical problem, as because of the use of powerfull antibiotics and other
drugs, and therapeutic measures, the number of patients, as well as the mortality haven't been changed for years. Because of that the study of pathogenesis of bacterial meningitis has been one the most dynamic researsh fields in recent years. Meningitis caused by salmonella is not usual clinical manifestation of salmonella infections, but because of fulminant evolution and specific structure of cause. Path and effect of diseases, it deserves special attention. Our researches encompases 29 children who suffer from salmonella meningitis. Out of the whole number of cured children, the moust frequent was at newborn (58,6%), while the smallest number was in the group of older infant (6.9%). Concernig the sex structure of diseased, the biger number was at male (62.0%). The most important finding in liquor cerebrospinalis at patients is polymorphonuclear leucocytosis (average value of cell elements is 3744, with 82% polymorphonuclears). At the same time existed leucocytosis in peripheral blood with sigificant deviation into left. At all our patients hypoglycorachya expressed (1.45mmol/L). The value of proteinorachya was 1.71 g/L. The result of the disease was successful in 49.3%, died 24,1%, and cured with consequences 27,6%.

D. Odalović, M. Perić, J. Putica, M. Čukalović, S. Jovanović, D. Ristić, A. Odalović

01.01.2003.

Professional paper

EPIDEMIC OF HEPATITIS A IN AREA OF TOPLICA

Hepatitis A is relatively benign disease. The duration of illness caused by HAV is variable, ranging from several
weeks to several mounths. Infection with HAV does not cause chronic liver disease. We have presented the clinical and
st epidemiological caracteristic an epidemic of hepatitis A in area of Toplica. Since late septembar 2001 to february of 21 in
2002, in hospital in Prokuplje have been treated 211 patients. The epidemic is spread by contact

N. Stamenković, S. Denić, M. Stevanović, S. Jovanović, M. Petrović

Indexed by